Private Equity and Debt Placement –
Life Sciences / Ag Biotech
Buy Side M&A Advisory –
Life Sciences / Ag Biotech January
Stephens Inc. advised Inguran LLC, commonly known as Sexing
Technologies, on the purchase of controlling interest in XY, Inc.
with $28.5 million Series A Preferred Stock and a $5.0 million
Standby Equity commitment. On November 20, 2007, Inguran completed
a second closing of $11.5 million Preferred & Common Equity and
$10.0 million in Subordinated Notes. The second closing provided
capital to complete the merger. Stephens Inc. acted as financial
advisor in connection with the transaction and acted as Inguran’s
exclusive placement agent on the financing.